Asbjørn
Rubinmedlem
Finnes det noen skikkelig dokumentasjon på påstanden om at vaksinene gir mildere sykdomsforløp?
Det hjelper ikke så mye med dokumentasjon når du omhyggelig unngår å lese den. Prøv her, om du tør eksponere deg for noe slikt:Jeg hadde forestilt meg noe mer vitenskapelig. Alle er enige om at vaksinen gir et midlere sykdomsforløp. Dette er hovedargumentet til de som er for vaksiner etter at det kom frem at de ikke hindrer smittespredning. Jeg synes slike påstander bør dokumenteres. Jeg antar at det finnes dokumentasjon ett eller annet sted, men jeg har til gode å se en slik dokumentasjon.
Prevention and Attenuation of COVID-19 by BNT162b2 and mRNA-1273 Vaccines
BACKGROUND Information is limited on messenger RNA (mRNA) BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) COVID-19 vaccine effectiveness (VE) in preventing SARS-CoV-2 infection or attenuating disease when administered in real-world conditions. METHODS Prospective cohorts of 3,975 healthcare...
www.medrxiv.org
Eller her:Authorized mRNA vaccines were highly effective among working-age adults in preventing SARS-CoV-2 infections when administered in real-world conditions and attenuated viral RNA load, febrile symptoms, and illness duration among those with breakthrough infection despite vaccination.
The Lancet: First nation-wide data shows two doses of Pfizer-BioNTech vaccine highly effective against COVID-19 infection, hospitalisation, and death
Two doses of the Pfizer-BioNTech COVID-19 vaccine provide more than 95% protection against infection, hospitalisation, severe illness, and death, including among the elderly, according to the first national-level observational assessment of its effectiveness in Israel, published in The Lancet.
www.eurekalert.org
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00947-8/fulltext
- Israel is the first country to report national data on the Pfizer-BioNTech vaccine, with observational analysis showing that two doses provide more than 95% protection against COVID-19 infection, hospitalisation, and death, including among the elderly, at a time when the B.1.1.7 variant was the dominant strain.
- A single dose of the vaccine was associated with 58% protection against infection, 76% against hospitalisation, and 77% against death, emphasising the importance of fully vaccinating adults.
Eller her eller her:
Sist redigert: